Griffith Open: No conditions. Results ordered -Date Deposited. 2024-03-29T09:33:29ZEPrintshttps://go.griffith.ie/images/sitelogo.pnghttp://go.griffith.ie/2022-03-05T22:19:37Z2022-10-10T16:50:52Zhttp://go.griffith.ie/id/eprint/510This item is in the repository with the URL: http://go.griffith.ie/id/eprint/5102022-03-05T22:19:37ZSupporting Students with Neurological Differences in the Classroom - Promoting diversity and inclusion of neurodiverse students within Higher EducationThe goal of this webinar is to celebrate neurodiversity and promote how it can be harnessed to encourage greater engagement and creativity within the learning environment.
Participants can expect to walk away with a clear, basic understanding of neurodiversity, the challenges faced by neurodiverse learners and how these challenges can be addressed. Using principles of best practice in this area, contributors will discuss some achievable practical teaching strategies that have the potential to be inclusive, flexible and engaging for neurodiverse students.
Intended learning objectives of the session:
- Support diverse cohorts of students better using practical strategies
- Discuss learning challenges associated with neurological differences such as ADHD, Autism, Dyslexia and Dyspraxia
- Explore strategies based on neurodiversity
- Plan to use strategies to encourage student success for all students
Panelists:
- Fiona Ferris: Deputy CEO of AsIAm, Ireland's National Autism Charity and Advocacy Organisation.
Presentation: Building an Inclusive Culture in Higher Education
- Nicola James: CEO and founding director of Lexxic, a consultancy providing specialist support and dyslexia/ AD(H)D e-learning services for individuals in the workplace and higher education.
Presentation: Empowering Neurodiverse Students.
Change One Thing
Repository of resources to support neurodiverse students
Following on from the webinar, a repository of resources to support implementing practical, immediate changes to teaching practice was made available:
https://library.griffith.ie/lecturer-support/change-one-thing-repository/Orla ButlerDimphne Ni Bhraonain2022-01-19T21:51:00Z2022-01-19T21:51:00Zhttp://go.griffith.ie/id/eprint/509This item is in the repository with the URL: http://go.griffith.ie/id/eprint/5092022-01-19T21:51:00ZR&D innovative technologiesin the pharmaceutical sector and the challenges in their implementation in the EUThe pharmaceutical industry is constantly changing, and patients necessities waiting for treatment are numerous. New diseases and those that do not have treatment are constant factors demanding the pharmaceutical industry look at recent trends in R&D, search for different scientific solutions, and focus on innovation. It is essential to know the R&D innovative technologies, applications, and development in the current landscape, driving the pharmaceutical sector forward. In the new context, where the European Union has 27 countries, the European Medicines Agency (EMA) regulates approvals and population worldwide lives in the context of the Covid-19 pandemic. The vision of opting for new technology, knowing the trends in R&D, science, and innovation opens a panorama of opportunities and challenges for the pharmaceutical sector. The study comprises qualitative and quantitative approaches to investigated innovative technologies and their challenges in pharmaceutical R&D. Data generation have been carried out with scientists working in R&D, pharmaceutical professionals, and regulatory professionals, followed by an analysis of information available through documentary research. Findings have shown that the most challenging factor influencing the R&D innovative technology approval is regulatory standardization. This factor has led to the major constraint in implementing innovative technologies, while Technology cost has been identified as the second challenging constraint. R&D innovative technologies represent an advantage in a COVID-19 pandemic context through gene therapies and digital transformation with access to big data in real-time. R&D management performs a principal role in the implementation of new technology. As Claud-based data management has been the main Pharma 4.0 element implemented in the EU in recent years, Policy and regulatory activity and Data integrity and cybersecurity will represent the pharmaceutical sector's major challenges in the next ten years.Berenice Erreguin Luna2022-01-19T21:41:31Z2022-01-19T21:41:31Zhttp://go.griffith.ie/id/eprint/506This item is in the repository with the URL: http://go.griffith.ie/id/eprint/5062022-01-19T21:41:31ZThe Study of the Key Challenges Facing Pharmaceutical Manufacturing Industry in Lagos, Nigeria, With Emphasis on Cost and Access to Quality Raw MaterialThe Nigerian pharmaceutical manufacturing industry is very important to the economy of Nigeria. From empirical research already done on the Nigerian pharmaceutical industry, it was
gathered that several challenges drag the development of the sector. This gave good understanding about this work which aims to study the challenges facing the pharmaceutical
manufacturing industry in Lagos, Nigeria with emphasis on cost and access to quality raw materials.
Considerably, 25% of the pharmaceutical products required by Nigerians are locally delivered by Nigeria’s pharmaceutical industry. The excess 75% are imported from other developed
nations like UK, India and China (WHO/PQT, 2014).
The Research Onion proposed by Saunders and his colleagues Lewis and Thornhill in 2009 forms the bases and provides the structure for the research process used in this study. Central
in the context of this dissertation is the research philosophy of interpretivism. The research approach was deductive and aimed to collect data and build a theory based on the results
(Saunders, Lewis and Thornhill, 2009). A case study strategy was used to properly understand the challenges especially in the area of cost and access to quality raw materials, facing the four pharmaceutical manufacturing firms employed in this study. A mono method research choice (only qualitative research strategy) was adopted for the collection of data. Then data were collected and analysed into themes which assisted in the overall research findings. The results from this study on the accessibility of raw material reveal that all the pharmaceutical firms in Nigeria rely heavily on the importation of raw materials. On the affordability of quality
raw materials, all data collected pointed to the fact that the prices of quality materials are becoming increasingly expensive and unaffordable. On the impact of accessibility to quality raw materials on the production capacity, this study revealed that accessibility to quality materials dramatically influences the production capability of pharmaceutical firms in Nigeria.
Lastly, on the impact of cost of quality raw materials on the production capacity, this study revealed that the cost of the materials is prohibitive.Ojo Nathaniel Olatokunbo2022-01-19T21:25:51Z2022-01-19T21:25:51Zhttp://go.griffith.ie/id/eprint/507This item is in the repository with the URL: http://go.griffith.ie/id/eprint/5072022-01-19T21:25:51ZA Quantitative Study on Factors Associated with the Implementation and Uptake of Paediatric Vaccination in India and IrelandVaccinations are the simplest, safest and cost-effective method to protect population from infectious diseases by boosting a person’s immune system. It is important to enhance Paediatric immunogenicity as they are at high risk of getting serious infectious disease by harmful germs. Parents and healthcare professionals play an important role in the coverage rate of vaccination among children. Despite the success of Paediatric vaccination, the coverage rate of child immunization is very less in certain countries. It is essential to evaluate parental behaviour and knowledge of healthcare professionals about child immunization and to identify the factors associated with the implementation and uptake of childhood vaccination to improve the practice of Paediatric vaccination.
Method:
A cross-sectional quantitative study was undertaken on parents and healthcare professionals, who live in Ireland and India. A total of 133 participants; 69 parents and 64 healthcare professionals were involved in the study. Specifically developed questionnaire used to collect data from participants through email and mobile apps.Nithya Maria George2022-01-17T12:12:41Z2022-01-17T12:12:41Zhttp://go.griffith.ie/id/eprint/504This item is in the repository with the URL: http://go.griffith.ie/id/eprint/5042022-01-17T12:12:41ZBarriers that Restrict Patient Involvement in Drug Development: An Industrial PerspectiveObjective:
To explore the barriers restricting the implementation of patient involvement in drug development(PIDD)from an industrial perspective and to get insights on knowledge and awareness of pharmaceutical employees around PIDD and its various facets.
Methods:
A questionnaire-based survey (n=51) was conducted among the pharmaceutical employees currently working in Research and Development, to seek information regarding barriers pertaining to patient involvement in drug development. The study participants were evaluated for their understanding and awareness around the subject to get insights on the persisting knowledge gaps. The data was analysed descriptively and interpretatively, based on the type of responses obtained.
Results:
In the study, 74% of the respondents considered lack of dedicated groups as a likely factor hurdling the execution of PIDD. In addition, a total of 62% of the employees corresponded lack of industrial confidence in patient knowledge and skills to hinder the effective industrial implementation of the concept, while 16% of the participants considered proper representation of patient population for PIDD activities unlikely to cause hurdles. Insights on participant’s knowledge and awareness on PIDD and its support organisation, revealed it to beaverage, considering their close associations with drug development activities. Recommendations for improving the current state of patient involvement in drug development were primarily directed towards enhancing knowledge base around the topic, reforming the current industrial practices to better involve patients and strengthening regulations around PIDD.
Conclusion:
Despite increasing efforts from patient organisations in promoting PIDD within industrial practices by empowering patients through trainings and by coming up with recommendations to recognize patients as equal partners in the venture, there still exists barriers that hinder its practicality. Bridging the gap between the conceptual theories and functionalism is necessary and requires identifying the factors posing challenges and overcoming them by establishing means to improve patient involvement. Assessing the value of methods offered for PIDD execution, expanding the population range and utilising information from regulatory database to gain insights on the state of PIDD, allows for further research.Ria Rose Roy2022-01-17T11:56:06Z2022-01-17T11:56:06Zhttp://go.griffith.ie/id/eprint/503This item is in the repository with the URL: http://go.griffith.ie/id/eprint/5032022-01-17T11:56:06ZThe Study of the Role of Digital Transformation on the Pharmaceutical Manufacturing Process in the Nigerian Pharmaceutical Industry.In this dissertation, an exploration of the role of digital transformation in the Nigerian pharmaceutical manufacturing industry was studied. The study was constructed around descriptive primary exploratory research design and a qualitative research method was used in achieving a robust understanding of the relevance of digital transformation and various advanced digital tools in a pharmaceutical manufacturing operation in the wake of the recent industrial 4.0 revolution and hence pharma 4.0 concept which entails being smart and efficient in achieving manufacturing excellence. To achieve this aim, a purposive snowballing sampling technique was used in enlisting Ten (10) pharmaceutical industry experts who are familiar with pharmaceutical manufacturing operations and knowledgeable on the various industrial developments around them. Using mobile phone calls, five (5) separate in-depth semi-structured interviews were successfully conducted with the five of the experts who were sourced from different secondary drug-producing companies in Nigeria. In the interviews conducted, sixteen (16) questions, formulated through inductive reasoning, were used as a guide and all responses were audiotaped, transcribed into text equivalent, and analyzed using thematic content analysis. In the analysis of the interview data, six major themes were identified and discussed. The study found out that while there is an awareness of the concept of digital transformation in the Nigerian pharmaceutical industry environment, the industry is nevertheless “digitally immature” as the manufacturing process is exclusively driven by traditional. It is as well found out in the study digital transformation comes with the potential to achieve operational excellence (measured in term of reduced waste, decreased error/batch defect rate, improved product quality, less equipment downtime, etc.) and contribute to business excellence by positively impacting the business model of pharma companies in Nigeria which is based on speed to market and competitive pricing that requires efficient production and effective cross-functional supply chain integration). While these were identified as some of the endless potentials of digital transformation in pharma manufacturing, cultivating a digital mindset was found to be an integral initiative in achieving digital transformation in the Nigerian manufacturing industry environment which is not free of challenges. Factors including poor infrastructural developments, lack of investment and resources were identified as “general barrier/challenges” while factors including knowledge gap, lack of expertise, and regulatory hurdles were identified as “industry-specific barriers/challenges” faced by Nigerian pharmaceutical companies in embracing pharma 4.0 model and achieving digital transformation and hence making the industry to be digitally immature.Motunrayo Oluderu2022-01-17T11:50:07Z2022-01-17T11:50:07Zhttp://go.griffith.ie/id/eprint/502This item is in the repository with the URL: http://go.griffith.ie/id/eprint/5022022-01-17T11:50:07ZThe Impact of Lean and Modularity on Pharmaceutical Facilities in IrelandModularity is a systematic process where the various modules of a system or product can be combined in multiple ways to form a different product or system while Lean is a user-centric approach that focuses on continuous improvement, waste elimination and project management. This piece of research is an exploratory study aimed at investigating the adoption of Modularity and Lean in pharmaceutical facilities in Ireland. This research analyzed Pharmaceutical production managers, quality managers and construction Engineers who have implemented Lean and Modularity in the development or operation of production facilities. A mixed method questionnaire survey was sent to pharmaceutical personnel involved in the implementation of Lean and Modularity to analyze the critical areas of Lean manufacturing and modular manufacturing within the pharmaceutical industry. The various Topics associated with Modularity and Lean such as benefits, challenges and contributing factors to implementation success were examined within the questions. The results obtained show that facilities implemented Modularity extensively in the production area and its components while there has been a moderate to extensive implementation of lean across critical areas. It was concluded that pharmaceutical facilities valued scalability, flexibility, order, and waste elimination.Ayodeji Awe2022-01-17T11:42:00Z2022-01-17T11:42:00Zhttp://go.griffith.ie/id/eprint/501This item is in the repository with the URL: http://go.griffith.ie/id/eprint/5012022-01-17T11:42:00ZAntidepressants among Healthcare Professionals in South India1.Background
Antidepressants are drugs which are used to relieve the symptoms of depressive disorders. The clinical awareness about physical, mental and social factors of a patient is very keen in deciding an optimal antidepressant therapy. The rational use of antidepressant must be monitored very carefully as inappropriate use can lead to its abuse and overuse
2. Purpose
This study aims to evaluate the knowledge and attitude towards, antidepressant drugs among the healthcare professionals working in South India. This is to analyse the issues involved in practicing antidepressant therapy and review the methods to ameliorate and enhance the implementation of antidepressants.
3. Design and methodology
The study involved deductive approach as well as qualitative and quantitative analysis was done for the questionnaire-based survey conducted among 50 healthcare professionals in South India. The secondary data was acquired from an analysis of current research articles on antidepressants and its abuse and overuse and the measures to curtail these issues.
4. Findings
Eighty four percent of the participants reported that the main cause for antidepressant abuse and overuse is the inappropriate use of antidepressants. Considering, pharmaceutical companies’ intervention, there was a strong agreement from the study group at seventy four percent while twenty four percent gave a neutral response. A large proportion of the healthcare professionals agree that outpatients pressurise them to prescribe or dispense antidepressants.
5. Conclusion
The participants had adequate understanding of general antidepressant use. Lack of knowledge can be curtailed by the implementation of antidepressant awareness programs. Healthcare professionals should be motivated to attend training programmes to reduce the abuse and overuse of antidepressants.Athul Mathew2022-01-17T11:35:00Z2022-01-17T11:35:00Zhttp://go.griffith.ie/id/eprint/500This item is in the repository with the URL: http://go.griffith.ie/id/eprint/5002022-01-17T11:35:00ZAn Analysis Of Factors Contributing To Successful Implementation Of Flu Vaccine Programmes In IrelandInfluenza is a contagious respiratory illness caused by the influenza virus. Influenza epidemics result in higher hospitalization and medical costs, as well as higher labour absence and poorer productivity. Vaccination is a simple, safe, and effective way to protect people from contagious viruses when they make contact with them. This study focuses on the factors that contribute to the successful implementation of flu vaccine programmes among the Irish population. The study also focuses on to the perspective of Irish population towards flu vaccine as well as the situation in Ireland regarding the Flu. The study was conducted in Ireland’s capital, Dublin.
OBJECTIVE:
To outline the situation in Ireland with regard to Flu vaccinations, to identify the major determining factors for the effective implementation of flu vaccination programs among Irish citizens and to identify the perspective of Irish population towards flu vaccinations .
METHODOLOGY:
It is a cross-sectional quantitative study. The primary data was collected through the survey conducted with the help of a closed ended questionnaire. 185 people participated in the survey and their response to the questions were considered as the basis of this study.
RESULTS:
Result of the study found that the factors including Place to get vaccination, source of information, mandatory vaccination programmes, cost, time, safety issues etc plays a critical role successful implementation of flu vaccine programmes in Ireland.
CONCLUSION:
The vaccine coverage in the country can be improved by providing maximum education, awareness programmes and campaigns by tackling myths, hurdles, and misunderstandings of flu vaccination.Jeethumol George2022-01-17T11:26:08Z2022-01-17T11:26:08Zhttp://go.griffith.ie/id/eprint/499This item is in the repository with the URL: http://go.griffith.ie/id/eprint/4992022-01-17T11:26:08ZThe Technological Readiness of Pharmaceutical Companies in Ireland facing Pharma 4.0The aim of this research was to measure the technological readiness of pharmaceutical companies in Ireland facing Pharma 4.0. Also, describe the triggers and challenges in adhering to the operational model implementation. Through the application of surveys to employees belonging to the pharmaceutical industry workforce, valuable data could be obtained, which was quantified. Using digital maturity measurement instruments was possible to locate the Irish pharmaceutical industry is in the visibility stage which represents a basic level of Pharma 4.0 implementation.
Motivated by the increase in its production, but challenged by the monetary and logistical implications of acquiring new technologies.
The significance of this study is that it allows obtaining a general description of the level of presence of Pharma 4.0 in the entire pharmaceutical industry. Allowing to show the strength and weaknesses in the capabilities currently present in the industry.Karla Iveth Rodriguez Lagos2022-01-17T11:17:29Z2022-01-17T11:17:29Zhttp://go.griffith.ie/id/eprint/498This item is in the repository with the URL: http://go.griffith.ie/id/eprint/4982022-01-17T11:17:29ZLimitations Impacting Local Manufacturing of Vaccines: A Nigeria Case StudyVaccination is an age long science that has been proven to prevent some deadly diseases, especially in children below the age of 5years. Therefore, it is empirical for any nation to stimulate the process of immunization and ensure that children and adults are protected from some of these infectious and deadly diseases. This will bring about a safe, healthy, and productive society where every individual within the system contributes their quota to the Gross Domestic Product (GDP) rather than treating the overall consequences of the lack of vaccination.This research work was initiated to critically consider the limitations that impact local manufacturing of vaccines in Nigeria. A review of various literature from articles, journals, workshop presentations at different scientific conferences and other sources on related topics, to see trends and events as it relates to effort made in local vaccines manufacturing. From the literature reviewed, it was evident that most of the vaccines production are from developed countries like china, India, Russia, Vietnam, United States of America, Europe with very few Africa countries currently manufacturing vaccines locally.In this research, qualitative method and Interpretivism philosophy of interviews arranged with experts on this subject matter were employed. Due to the prevailing pandemic ravaging the world, the researcher could not have a face-to-face interview with the identified experts contacted to be part of this research. Therefore, zoom meetings were set up and responses to the questions asked were all recorded and transcribed during the data analysis process. This process adequately ensured that the data collection process was effectively managed and with the use of thematic analysis, which is considered the most effective and preferred method used in qualitative data analysis based on its enormous benefits.From the data analyzed using the answers provided by the experts interviewed in this research work, some findings inferred. There is no vaccine currently manufactured locally in Nigeria. Advocacy could be considered a strong tool in achieving local manufacturing of vaccines. There are available government policies on local manufacturing of vaccines, but the problem majorly is the lack of policy implementation.Although the pharmaceutical industries are willing to engage in local manufacturing of vaccines. Also, the challenges facing the pharmaceutical industries in achieving local manufacturing of vaccines are numerous but could be upturned with government support. My researcher work has been able to identify some solution through the various recommendations and suggestions as discussed in chapter 5 of this dissertation. If these highlighted issues are implemented, then achieving local manufacturing of vaccines could be easily achieved and in good time.Omoniyi Sunday Adesanya2022-01-17T10:58:45Z2022-01-17T10:58:45Zhttp://go.griffith.ie/id/eprint/496This item is in the repository with the URL: http://go.griffith.ie/id/eprint/4962022-01-17T10:58:45Z1A comparative study of Regulatory systems and Quality management practices in the manufacturing process of different pharmaceutical companies in Nigeria.This thesis aims to examine and compare different pharmaceutical manufacturing companies in Nigeria(local and foreign). There will be an examination of regulatory systems and quality management practices in the company and their impact on the quality and availability of medicinal products in the region. The opinion of medical doctors, pharmacists and consumers concerning the products from foreign and Nigerian pharmaceutical companies would also be considered when examining the impact of company quality system on the products. This aim would be achieved by way of conducting quantitative questionnaire survey and qualitative reviews of literature.A cross-sectional survey with 50 participants including medical doctors, pharmacists and consumers was carried out and literature about the regulatory systems and quality management practices of the were reviewed and the results showed the regulatory system in Nigeria is not effective and the entire pharmaceutical sector of has loopholes that make the system inefficient. The research was also able to identify the factors that influence the quality and availability of medicinal products manufactured in Nigeria which include Socio Economic status of the country,Inadequate laws or poor enforcement of the existing regulations/guidelines for manufacturing of good quality medicinal products,Inadequate funding/support for Nigerian pharmaceutical manufacturing companies,Demand exceeding supply and high cost of good quality medicinal product. NAFDAC has put in efforts over the years to improve their system but there are still important changes that need to be made. The study recommend that NAFDAC makes the Nigerian Pharmaceutical sector more transparent with its activities and more funding should be made available to the Nigerian pharmaceutical companies. Also should be set up to ensure that the NAFDAC officials carry out their duties effectively and they should be paid properly for it.Anyiam Chioma Awele2022-01-17T10:47:02Z2022-01-17T10:47:02Zhttp://go.griffith.ie/id/eprint/495This item is in the repository with the URL: http://go.griffith.ie/id/eprint/4952022-01-17T10:47:02ZThe Role and Impact of Process Analytical Technology (PAT) on Solid Dose Manufacturing in NigeriaThis research investigated the role and impact of Process Analytical Technology (PAT) on solid dose manufacturing in the Nigerian pharmaceutical industry. PAT has been generally adjudged to be a promising technology that can significantly improve manufacturing efficiency and reduce the cost of production. There is evidence to back this point of view based on the automotive industry and other industries that have successfully implemented PAT. However, regardless of the demonstrated benefits of PAT, manufacturers in the pharmaceutical industry seem too slow to implement it in their manufacturing process. Realising this, the United States Food and Drug Administration (FDA) enacted a series of initiatives to drive a regulatory framework that could motivate manufacturers in the pharmaceutical industry to implement PAT. Nigeria represents one of the biggest pharmaceutical market in the world by virtue of its population which is estimated to be the biggest in Africa where PAT could help deliver quality medication at affordable rates. To investigate the role and impact of PAT in the Nigerian pharmaceutical industry, this research adopted a quantitative approach whereby self-administered questionnaires were sent to manufacturers through an online Google Form. The list of registered pharmaceutical manufacturers was obtained from NAFDAC, the regulator of the industry in Nigeria. Out of about 130 established manufacturers, 62 responses were obtained. Based on inferential statistics, the results show that indeed PAT plays a role in the Nigerian pharmaceutical industry albeit an insignificant one. Out of about twenty-one (21) identified challenges, eleven (11) were statistically significant. The most significant challenges that the respondents agreed the strongest to relate to the cost of implementing PAT. Although the hypotheses tested revealed that PAT has a significant effect on the price, quality and effectiveness of solid dosage forms, the general experience of health practitioners could not justify PAT adoption. Therefore, it is recommended that manufacturers in the Nigerian pharmaceutical industry must think long term in order to overcome the hurdle of the initial cost of implementing PAT. The regulator of the industry must find strategies of making pharmaceutical manufacturing attractive so as to drive innovation from the manufacturers.Chinedu Nnadozie Chukwu2022-01-17T10:41:40Z2022-01-17T10:41:40Zhttp://go.griffith.ie/id/eprint/494This item is in the repository with the URL: http://go.griffith.ie/id/eprint/4942022-01-17T10:41:40ZImpact of Post Marketing Surveillance on Falsified Medicine in NigeriaThe thesis aims to evaluate the impacts of post marketing surveillance on falsified medicines among healthcare professionals (medical doctors and pharmacists) and consumers in Nigeria by conducting a questionnaire-based survey for quantitative research. in order to achieve this, the awareness and knowledge of falsified medicines, factors affecting effective post marketing surveillance in Nigeria and recommendations to improve adequate post marketing surveillance of falsified medicine in Nigeria.
The healthcare professionals (medical doctors and pharmacists) and consumers were evaluated to ascertain their level of awareness and knowledge of falsified medicines, healthcare professionals’ direct experiences to post marketing surveillance guidelines and frequencies of falsified medicine cases during their experience. The efficiency of Mobile Authentication Services (MAS). Sixty-six (66) respondents voluntarily participated and responded accordingly to the questionnaire structured survey.20 (30.0%) respondents were medical doctors, 24 (36.0%) respondents were pharmacists while 22 (33.0%) respondents were consumers. There was an absolute 100.0% respondents to willingness to update their knowledge about guidelines and regulations of post marketing surveillance of falsified medicine. Their most preferred method was through current guidelines from regulatory bodies.
There were factors associated with inadequate impacts of post marketing surveillance which included NAFDAC regulatory policies, social economic status of the country and cost implications. Increasing awareness of falsified medicines was recommended to be implemented by continuous advertisements through internet, radios and newspapers. Designing and implementing new applicable regulations to help improve post marketing surveillance.Chukwudi Anthony Mgboko2022-01-17T10:34:45Z2022-01-17T10:34:45Zhttp://go.griffith.ie/id/eprint/493This item is in the repository with the URL: http://go.griffith.ie/id/eprint/4932022-01-17T10:34:45ZEffects of GMP Trends on the Pharmaceutical Industry in NigeriaThe pharmaceutical industry is important to the economies of the world and for the preservation and promotion of the health of the human society. It is the industry that narrows the gap existing between health-span (disease-free lifetime) and lifespan, so that human beings can live longer and better lives. Therefore, good manufacturing practices are regulations/rules put in place to guide the conduct and operations of pharmaceutical firms to safeguard public health and safety from counterfeit, contaminated or falsified medications. There are trends that have emerged within the GMP space in the pharmaceutical industry which is what this research study has tried to investigate within the pharmaceutical industry in Nigeria. The gaps that exist in the subject area after literature search informed the objectives of the study which seeks to examine the perceptions of professionals regarding GMP trends in the pharmaceutical industry in Nigeria; evaluate the impact of technology in the implementation of GMP on the pharmaceutical industry in Nigeria; find out the impact of quality assurance as part of GMP trends on the pharmaceutical industry in Nigeria; and examine the effects of new drug safety issues as part of GMP trends on the pharmaceutical industry in Nigeria. To execute the study, exploratory design using qualitative research method in whichfive(5)participants were selected through the convenience sampling technique was deployed. Semi-structured interviews were initiated through Google Meet to collect qualitative data from the interviewees. Gioia qualitative data analysis technique was employed to analyse the collected qualitative data. The study reveals that (i) based on professionals’ perceptions, GMP trends in the pharmaceutical industry in Nigeria are characterised by trust, safety and quality; (ii) technology in the implementation of GMP trends in the pharmaceutical industry affects the entire product life cycle of pharmaceutical products; (iii) quality assurance as part of GMP trends in the pharmaceutical industry inNigeria improves public health; and lastly (iv) new drug safety issues as part of GMP trends influence continuous drug products’ monitoring for public safety.Findings show that GMP trends in the pharmaceutical industry have improved the industry but there is still room for growth and further development if the industry is to rival its counterparts in the rest the developed world especially in the area of greater technology adoption and tightening of the regulatory framework guiding the industry. The contribution of the current study will benefit academic researchers, regulators, pharmaceutical products’ manufacturers, consumers and government.Olanrewaju Olalekan Onafuwa2022-01-17T10:26:03Z2022-01-17T10:26:03Zhttp://go.griffith.ie/id/eprint/492This item is in the repository with the URL: http://go.griffith.ie/id/eprint/4922022-01-17T10:26:03ZAn Analysis of Drug Distribution and Medication Errors to Improve Pharmaceutical Services in NigeriaThe problem of medication errors represents risks in public health with negative consequences on patient’s wellbeing. Globally, healthcare sectors face more challenges addressing the incidents of medication errors due to underlining factors such as severe funding shortfalls, low patient-physician ratio, inadequate infrastructure and low technological inputs amongst others. Given the foregoing, this study employed a qualitative research design aided with a key informant interview of seven public healthcare experts to examine the drug distribution and administration system of Nigeria's public healthcare setting. The primary data derived from public health experts with both theoretical and practical knowledge of Nigeria's public hospital settings were examined against the secondary data derived from the review of extant literature. The outcomes suggest that systemic problems such as the weak political will of the government to effectively fund its healthcare sector, low workers engagement, weak supervision, anemic enforcement, non-adherence to standard procedures, shortage of healthcare professionals (HCP), low patient awareness, poor organizational culture amongst others represent factors precipitating medication errors. To reverse these significant problems, the study made recommendations comprising the reimagining of the boards and the personnel administration of the hospitals to include individuals from the organized private sector, to enhance best practices and modern HRM practices. Others include the government should boost public funding for the sector, incentivize skilled and experienced HCPs to exercise better supervision, deploy automation to digitally safeguard the system, incentivize medical and nursing education to sustain recruitment pipeline, mandate periodic training for HCP, and the introduction of a mandatory patient awareness booklet to boost public awareness of what constitutes medication errors, the introduction of a mandatory clinical audit review of public hospitals to be conducted by a third party from the private sector, and reorganizing the governance boards of government administered to include non-bureaucrats and seasoned professionals. These are needed to greatly reduce the incident of medication errors in Nigeria's hospital settings.Talabi Babatunde Muyiwa